Brent DuBeshter

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi request reprint Endometrial cancer: the potential role of cervical cytology in current surgical staging
    Brent DuBeshter
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Strong Memorial Hospital, University of Rochester School of Medicine, 125 Lattimore Road, Rochester, NY 14620, USA
    Obstet Gynecol 101:445-50. 2003
  2. ncbi request reprint High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer
    Brent DuBeshter
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Wilmot Cancer Center, University of Rochester School of Medicine, 125 Lattimore Road, Rochester, NY 14620, USA
    Gynecol Oncol 94:383-6. 2004
  3. ncbi request reprint Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study
    J Tate Thigpen
    Division of Oncology, Department of Medicine, University of Mississippi School of Medicine, Jackson, USA
    J Clin Oncol 22:3902-8. 2004

Collaborators

  • David Guzick
  • J Tate Thigpen
  • Howard D Homesley
  • Shu Liao
  • John Malfetano
  • Robert A Burger
  • Mark F Brady

Detail Information

Publications3

  1. ncbi request reprint Endometrial cancer: the potential role of cervical cytology in current surgical staging
    Brent DuBeshter
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Strong Memorial Hospital, University of Rochester School of Medicine, 125 Lattimore Road, Rochester, NY 14620, USA
    Obstet Gynecol 101:445-50. 2003
    ..To evaluate cervical cytology, tumor grade from endometrial sampling, and myometrial invasion with the risk of nodal spread in endometrial cancer...
  2. ncbi request reprint High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer
    Brent DuBeshter
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Wilmot Cancer Center, University of Rochester School of Medicine, 125 Lattimore Road, Rochester, NY 14620, USA
    Gynecol Oncol 94:383-6. 2004
    ..To determine the efficacy of high-dose rate brachytherapy as adjuvant treatment for Stage I/II papillary serous or clear cell endometrial cancer...
  3. ncbi request reprint Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study
    J Tate Thigpen
    Division of Oncology, Department of Medicine, University of Mississippi School of Medicine, Jackson, USA
    J Clin Oncol 22:3902-8. 2004
    ..This trial of stage III, IV, or recurrent disease evaluated whether combining these agents increases response rate (RR) and prolongs progression-free survival (PFS) and overall survival (OS) over doxorubicin alone...